ArticleOpen forum infectious diseases2023

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials.

Todd Riccobene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.